Latest Omeprazole Stories
New research by the University of East Anglia (UEA) shows no risk in combining two commonly-prescribed treatments for patients at risk of heart attacks and strokes.
WHITEHOUSE STATION, N.J., April 1 /PRNewswire/ -- Merck & Co., Inc.
ROCKVILLE, Md., March 15 /PRNewswire-USNewswire/ -- Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a drug that prevents blood clots - were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Alerts patients, health care professionals to potential for reduced effectiveness SILVER SPRING, Md., March 12 /PRNewswire-USNewswire/ -- The U.S.
DEERFIELD, Ill., Feb.
CINCINNATI, Feb. 3 /PRNewswire/ -- For the New Orleans Saints, this past season has been marked as the winningest in franchise history, with a first time trip to Super Bowl XLIV.
NEW YORK, Jan. 25 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. ("NeoStem" or the "Company") (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S.
For years, the two most prevalent strategies for treating chronic gastroesophogeal reflux disease â€” commonly known as â€˜acid refluxâ€™ â€” have been prescription medications and surgery.
WHITEHOUSE STATION, N.J., Dec. 1 /PRNewswire/ -- Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.
ORLANDO, Fla., Nov.
- A woman chauffeur.
- A woman who operates an automobile.